Common use of Stock Exchange Listing Clause in Contracts

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 9 contracts

Samples: Underwriting Agreement (Hutchinson Technology Inc), Underwriting Agreement (Carey International Inc), Underwriting Agreement (Rent Way Inc)

AutoNDA by SimpleDocs

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National Global Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Market is contemplating terminating such registration or listing.

Appears in 8 contracts

Samples: Open Market Sale Agreement (Selecta Biosciences Inc), Open Market Sale Agreement (Selecta Biosciences Inc), Sales Agreement (Selecta Biosciences Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National NASDAQ Capital Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National NASDAQ Capital Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ Capital Market is contemplating terminating such registration or listing.

Appears in 8 contracts

Samples: Underwriting Agreement (Exact Sciences Corp), Underwriting Agreement (Exact Sciences Corp), Underwriting Agreement (Exact Sciences Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National Global Select Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National Global Select Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Select Market is contemplating terminating such registration or listing.

Appears in 7 contracts

Samples: Sales Agreement (Solid Biosciences Inc.), Sales Agreement (Solid Biosciences Inc.), Sales Agreement (Kala Pharmaceuticals, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National The NASDAQ Capital Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National The NASDAQ Capital Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") The NASDAQ Capital Market is contemplating terminating such registration or listing.

Appears in 6 contracts

Samples: Underwriting Agreement (Dynavax Technologies Corp), Underwriting Agreement (Dynavax Technologies Corp), Underwriting Agreement (Dynavax Technologies Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on The NASDAQ Global Select Market (the Nasdaq National Market“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock such shares from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of NASDAQ.

Appears in 6 contracts

Samples: Underwriting Agreement (Gladstone Commercial Corp), Underwriting Agreement (Gladstone Commercial Corp), Underwriting Agreement (GLADSTONE LAND Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National MarketNasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Placement Shares under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing.

Appears in 6 contracts

Samples: Equity Distribution Agreement (American Realty Capital Properties, Inc.), Equity Distribution Agreement (American Realty Capital Properties, Inc.), Equity Distribution Agreement (American Realty Capital Properties, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the "Exchange Act") and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 5 contracts

Samples: Underwriting Agreement (Exar Corp), Underwriting Agreement (Healthcare Financial Partners Inc), Underwriting Agreement (JDS Uniphase Corp /Ca/)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 4 contracts

Samples: Purchase Agreement (Uk Abba Products Inc), Purchase Agreement (Hutchinson Technology Inc), Purchase Agreement (Juno Lighting Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the The Nasdaq National Global Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 4 contracts

Samples: Open Market Sale Agreement (Affimed N.V.), Open Market Sale Agreement (Affimed N.V.), Open Market Sale Agreement (Affimed N.V.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National NASDAQ Global Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National NASDAQ Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ Global Market is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of NASDAQ.

Appears in 3 contracts

Samples: Underwriting Agreement (Celldex Therapeutics, Inc.), Underwriting Agreement (Celldex Therapeutics, Inc.), Underwriting Agreement (Celldex Therapeutics, Inc.)

Stock Exchange Listing. The Common Stock (Stock, including the Common Shares) , is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 3 contracts

Samples: Underwriting Agreement (Alphanet Solutions Inc), Underwriting Agreement (Alphanet Solutions Inc), Underwriting Agreement (Corporatefamily Solutions Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National MarketThe NASDAQ Stock Market (“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Underlying Securities under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing.

Appears in 3 contracts

Samples: Underwriting Agreement (American Realty Capital Properties, Inc.), Underwriting Agreement (American Realty Capital Properties, Inc.), Underwriting Agreement (American Realty Capital Properties, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National Global Market, and the . The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Market is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with the listing requirements of the Nasdaq Global Market applicable to the Company.

Appears in 3 contracts

Samples: Open Market Sale Agreement (Merus N.V.), Open Market Sale Agreement (Merus N.V.), Open Market Sale Agreement (Merus N.V.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National Capital Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National Capital Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Capital Market is contemplating terminating such registration or listing.

Appears in 3 contracts

Samples: Open Market Sale Agreement (BioXcel Therapeutics, Inc.), Open Market Sale Agreement (BioXcel Therapeutics, Inc.), Open Market Sale Agreement (BioXcel Therapeutics, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act Act, and is listed on the Nasdaq National MarketNASDAQ, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. Financial Industry Regulatory Authority (the "NASD"“FINRA”) is contemplating terminating such registration or listing. The Placement Shares have been authorized for listing, upon official notice of issuance, on the NASDAQ.

Appears in 3 contracts

Samples: Sales Agreement (Raptor Pharmaceutical Corp), Sales Agreement (Raptor Pharmaceutical Corp), Sales Agreement (Raptor Pharmaceutical Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or Section 12(g) of the Exchange Act and is listed on the Nasdaq National MarketNasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 3 contracts

Samples: Sales Agreement (Kezar Life Sciences, Inc.), Sales Agreement (Kezar Life Sciences, Inc.), Sales Agreement (Kezar Life Sciences, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the Nasdaq National MarketGlobal Select Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance in all material respects with all applicable listing requirements of Nasdaq.

Appears in 3 contracts

Samples: Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketGlobal Select Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance in all material respects with all applicable listing requirements of Nasdaq.

Appears in 3 contracts

Samples: Underwriting Agreement (ImmunityBio, Inc.), Placement Agency Agreement (ImmunityBio, Inc.), Placement Agency Agreement (ImmunityBio, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Select Market (the Nasdaq National Market“Exchange”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, Exchange nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Exchange is contemplating terminating such registration or listing. To the Company’s knowledge, it has complied in all material respects with the applicable requirements of the Exchange for maintenance of inclusion of the Common Stock on the Exchange.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Immersion Corp), Equity Distribution Agreement (Immersion Corp)

Stock Exchange Listing. The Common Stock (including the any shares of Common SharesStock issued in an Offering) is registered pursuant to Section 12(g) of under the Exchange Act and is or will as of the Closing Date be listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Nasdaq National Market, nor has the Company received any notification information suggesting that the Commission or the Nasdaq National Association of Securities Dealers, Inc. (the "NASD") Market is contemplating contemplated terminating such registration or listing.

Appears in 2 contracts

Samples: Placement Agency Agreement (Aksys LTD), Placement Agency Agreement (Sonic Solutions/Ca/)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketCapital Market (the “Exchange”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, Exchange nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Exchange is contemplating terminating such registration or listing. To the Company’s knowledge, it has complied in all material respects with the applicable requirements of the Exchange for maintenance of inclusion of the Common Stock on the Exchange.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Golden Matrix Group, Inc.), Equity Distribution Agreement (Broadwind, Inc.)

Stock Exchange Listing. The Company’s Common Stock (including the Common Shares) is has been registered pursuant to Section 12(g12(b) of the Exchange 1934 Act and is listed on the Nasdaq National MarketGlobal Select Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration or listing of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: At the Market Equity Offering Sales Agreement (Gladstone Commercial Corp), At the Market Equity Offering Sales Agreement (Gladstone Commercial Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act Act, and is listed on the Nasdaq National MarketNASDAQ Capital Market (the “NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. Financial Industry Regulatory Authority (the "NASD"“FINRA”) is contemplating terminating such registration or listing. The Offered Shares have been authorized for listing, upon official notice of issuance, on the NASDAQ.

Appears in 2 contracts

Samples: Underwriting Agreement (Syntroleum Corp), Underwriting Agreement (Raptor Pharmaceutical Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National Capital Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Capital Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Capital Market is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Underwriting Agreement (Dynavax Technologies Corp), Underwriting Agreement (Dynavax Technologies Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Market (the Nasdaq National Market“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the Nasdaq.

Appears in 2 contracts

Samples: Placement Agency Agreement (Presto Automation Inc.), Underwriting Agreement (Bellicum Pharmaceuticals, Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the "Exchange Act") and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Underwriting Agreement (Photon Dynamics Inc), Underwriting Agreement (Cyberonics Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the The Nasdaq National MarketGlobal Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 2 contracts

Samples: Underwriting Agreement (Astria Therapeutics, Inc.), Underwriting Agreement (Astria Therapeutics, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National MarketNasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 2 contracts

Samples: Sales Agreement (Axovant Gene Therapies Ltd.), Sales Agreement (Axovant Gene Therapies Ltd.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange 1934 Act and is listed on the Nasdaq National NASDAQ Global Market, and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange 1934 Act or delisting the Common Stock from the Nasdaq National NASDAQ Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ Global Market is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Purchase Agreement (Iconix Brand Group, Inc.), Purchase Agreement (Iconix Brand Group, Inc.)

Stock Exchange Listing. The Common Stock (including common stock of the Common Shares) Company is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on The NASDAQ Global Select Market (the Nasdaq National Market“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock common stock of the Company under the Exchange Act or delisting the Common Stock common stock of the Company from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of NASDAQ.

Appears in 2 contracts

Samples: Underwriting Agreement (Collegium Pharmaceutical, Inc), Underwriting Agreement (Collegium Pharmaceutical, Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The NASDAQ Global Select Market (the Nasdaq National Market“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock such shares from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of NASDAQ.

Appears in 2 contracts

Samples: Underwriting Agreement (GLADSTONE LAND Corp), Underwriting Agreement (GLADSTONE LAND Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Select Market (the Nasdaq National Market“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the Nasdaq.

Appears in 2 contracts

Samples: Underwriting Agreement (Scholar Rock Holding Corp), Placement Agency Agreement (Scholar Rock Holding Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National MarketGlobal Select Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 2 contracts

Samples: Underwriting Agreement (OptiNose, Inc.), Underwriting Agreement (OptiNose, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of under the Exchange Act and is listed on the Nasdaq National MarketNASDAQ Capital Market (“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification information suggesting that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating or suspending such registration or listing.

Appears in 2 contracts

Samples: Placement Agency Agreement (Staffing 360 Solutions, Inc.), Placement Agency Agreement (Staffing 360 Solutions, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and Act; the Common Stock (including the Common Shares) is listed included or has been approved for inclusion on the Nasdaq National Market, ; and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock (or the Common Shares) from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Underwriting Agreement (Red Robin Gourmet Burgers Inc), Underwriting Agreement (Red Robin Gourmet Burgers Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the Nasdaq National Market, Global Market (“Nasdaq”) and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 2 contracts

Samples: Underwriting Agreement (CareDx, Inc.), Underwriting Agreement (CareDx, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Capital Market (the Nasdaq National Market“Exchange”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, Exchange nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Exchange is contemplating terminating such registration or listing. To the Company’s knowledge, it has complied in all material respects with the applicable requirements of the Exchange for maintenance of inclusion of the Common Stock on the Exchange.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Serve Robotics Inc. /DE/), Equity Distribution Agreement (American Virtual Cloud Technologies, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketCapital Market (the “Exchange”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketExchange, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Exchange is contemplating terminating such registration or listing. To the Company’s knowledge, it has complied in all material respects with the applicable requirements of the Exchange for maintenance of inclusion of the Common Stock on the Exchange.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Aehr Test Systems), Equity Distribution Agreement (Aehr Test Systems)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketNASDAQ Capital Market (the “Exchange”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, Exchange nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Exchange is contemplating terminating such registration or listing. To the Company’s knowledge, it has complied in all material respects with the applicable requirements of the Exchange for maintenance of inclusion of the Common Stock on the Exchange.

Appears in 2 contracts

Samples: Equity Distribution Agreement (Atomera Inc), Equity Distribution Agreement (Atomera Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the The Nasdaq National MarketGlobal Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 2 contracts

Samples: Underwriting Agreement (KalVista Pharmaceuticals, Inc.), Sales Agreement (KalVista Pharmaceuticals, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) 12 of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 2 contracts

Samples: Underwriting Agreement (Redwood Trust Inc), Underwriting Agreement (Redwood Trust Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on The Nasdaq Global Market (the Nasdaq National Market“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 2 contracts

Samples: Underwriting Agreement (Cidara Therapeutics, Inc.), Underwriting Agreement (Cidara Therapeutics, Inc.)

Stock Exchange Listing. The Company's Common Stock Shares (including the Common Shares) is are registered pursuant to Section 12(g12(b) of the Exchange Act and is listed are included on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Charlotte Russe Holding Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National Market, and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Market is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Placement Agent Agreement (Sangamo Therapeutics, Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of under the Exchange Act and is listed on the Nasdaq National SmallCap Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification information suggesting that the Commission or the National Association of Securities Dealers, Inc. LLC (the "NASD") is contemplating terminating or suspending such registration or listing.

Appears in 1 contract

Samples: Placement Agency Agreement (Targeted Genetics Corp /Wa/)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National Capital Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Placement Shares under the Exchange Act or delisting the Common Stock from the Nasdaq National Capital Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Capital Market is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Equity Distribution Agreement (American Realty Capital Properties, Inc.)

Stock Exchange Listing. The Company’s Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketNASDAQ Global Market (“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of NASDAQ.

Appears in 1 contract

Samples: Underwriting Agreement (Curis Inc)

Stock Exchange Listing. The Common Stock (including the any shares of Common SharesStock issued in an Offering) is registered pursuant to Section 12(g) of under the Exchange Act and is or will be as of the Closing Date listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification information suggesting that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating or suspending such registration or listing.

Appears in 1 contract

Samples: Placement Agency Agreement (Sonic Solutions/Ca/)

Stock Exchange Listing. The Common Stock (including of the Common Shares) Company is registered pursuant to Section 12(g) of under the Exchange 1934 Act and is listed on the The Nasdaq National Market, and the . The Company has taken no action designed toto terminate, or likely to have the effect of, of terminating the registration of the its Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification information suggesting that the Commission or the National Association of Securities Dealers, Inc. LLC (the "NASD") is contemplating terminating or suspending such registration or listing.

Appears in 1 contract

Samples: Placement Agency Agreement (Biopure Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National MarketCapital Market of the NASDAQ, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor Capital Market of the NASDAQ. The Company has the Company not received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the NASDAQ.

Appears in 1 contract

Samples: Underwriting Agreement (Scilex Holding Co)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the Nasdaq National MarketNasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Open Market Sale Agreement (Concert Pharmaceuticals, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National Market, and NASDAQ Capital Market (the “NASDAQ”). The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the NASDAQ.

Appears in 1 contract

Samples: Underwriting Agreement (AxoGen, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, Market and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, Market nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Pathogenesis Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of under the Exchange Act and the Common Stock (including the Shares) is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification information that the Commission or the National Association of Securities Dealers, Inc. LLC (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Orchid Biosciences Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) 12(g)n of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Bone Care International Inc)

Stock Exchange Listing. The shares of Common Stock (including the Common Shares) is are registered pursuant to Section 12(g12(b) of the Exchange 1934 Act and is are listed on the Nasdaq National Global Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the shares of Common Stock under the Exchange 1934 Act or delisting the Common Stock shares from the Nasdaq National Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Market is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: At the Market Equity Offering Sales Agreement (Vical Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. Dealers LLC (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Recovery Engineering Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the "Exchange Act") and is listed on the Nasdaq National Market, Market and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Atrix Laboratories Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq NASDAQ National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq NASDAQ National Market, nor has the Company received any notification that the Commission or the NASDAQ National Association of Securities Dealers, Inc. (the "NASD") Market is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Purchase Agreement (Labone Inc/)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the "Exchange Act") and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.Company

Appears in 1 contract

Samples: Underwriting Agreement (Integrated Silicon Solution Inc)

AutoNDA by SimpleDocs

Stock Exchange Listing. The Common Stock (including common stock of the Common Shares) Company is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National Global Select Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock its common stock under the Exchange Act or delisting the Common Stock its common stock from the Nasdaq National Global Select Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Select Market is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Sabra Health Care REIT, Inc.)

Stock Exchange Listing. The shares of Common Stock (including the Common Shares) is are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the Nasdaq National MarketNasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the shares of Common Stock under the Exchange Act or delisting the shares of Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Underwriting Agreement (Viridian Therapeutics, Inc.\DE)

Stock Exchange Listing. The Common Stock (including common stock of the Common Shares) Company is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock its common stock under the Exchange Act or delisting the Common Stock its common stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Chattem Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the The Nasdaq National MarketGlobal Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock Shares under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Open Market Sale Agreement (Bellicum Pharmaceuticals, Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, Market and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Caminus Corp)

Stock Exchange Listing. The Common Stock (including the any shares of Common SharesStock issued in an Offering) is registered pursuant to Section 12(g) of under the Exchange Act and is or will be as of the Closing Date listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Nasdaq National Market, nor has the Company received any notification information suggesting that the Commission or the Nasdaq National Association of Securities Dealers, Inc. (the "NASD") Market is contemplating terminating or suspending such registration or listing.

Appears in 1 contract

Samples: Placement Agency Agreement (Aksys LTD)

Stock Exchange Listing. The Common Stock (including the Common Offered Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act Act, and is listed on the Nasdaq National Capital Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Capital Market, nor has the Company received any notification that the Commission Commission, the Nasdaq Stock Market LLC or the National Association of Securities DealersFinancial Industry Regulatory Authority, Inc. (the "NASD"“FINRA”) is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (MeetMe, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, Global Market and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Market is contemplating terminating such registration or of listing.

Appears in 1 contract

Samples: Underwriting Agreement (LHC Group, Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Global Select Market (the Nasdaq National Market“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Equity Distribution Agreement (Codexis, Inc.)

Stock Exchange Listing. The Common Stock (including including, upon issuance, the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed authorized for quotation on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Entremed Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Central Garden & Pet Co)

Stock Exchange Listing. The Company’s Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National MarketGlobal Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the shares of Common Stock under the Exchange Act or delisting the shares of Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Note Purchase Agreement (Horizon Pharma, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the The Nasdaq National MarketCapital Market (“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any written notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration registrations or listing. To the Company’s knowledge, it is in compliance all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Underwriting Agreement (Sanara MedTech Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of under the Exchange Act and is listed on the Nasdaq National Market, and Market (the “Nasdaq-NM”). The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from on the Nasdaq National MarketNasdaq-NM, nor has the Company received any notification information suggesting that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq-NM is contemplating terminating or suspending such registration or listing.

Appears in 1 contract

Samples: Placement Agency Agreement (Neogen Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National NASDAQ Global Select Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National NASDAQ Global Select Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Purchase Agreement (Stewart Enterprises Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange 1934 Act and is listed on the Nasdaq National Global Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange 1934 Act or delisting the Common Stock from the Nasdaq National Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Market is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Purchase Agreement (Iconix Brand Group, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. LLC (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Creditrust Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed toto terminate, or likely to have the effect ofof terminating, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Axsys Technologies Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, Market nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Analytical Surveys Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Capital Market (the Nasdaq National Market“Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Underwriting Agreement (Advaxis, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketCapital Market (the “Nasdaq”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the Nasdaq.

Appears in 1 contract

Samples: Underwriting Agreement (Vaxart, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Offered Shares) is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASD is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (United Pan Am Financial Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed (subject to notice of issuance in the case of the Common Shares) on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (American Superconductor Corp /De/)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is listed on the Nasdaq National MarketNASDAQ Global Market (the “NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Biosante Pharmaceuticals Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange 1934 Act and is listed on the The Nasdaq National Market, Global Select Market (“Nasdaq”) and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange 1934 Act or delisting the Common Stock shares from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, the Company is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: At the Market Equity Offering Sales Agreement (Arcellx, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on The NASDAQ Global Market (the Nasdaq National Market“NASDAQ”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock such shares from the Nasdaq National MarketNASDAQ, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASDAQ is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of NASDAQ.

Appears in 1 contract

Samples: Underwriting Agreement (GLADSTONE LAND Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the The Nasdaq National MarketGlobal Market (“Nasdaq”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Underwriting Agreement (Sesen Bio, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the Nasdaq National Global Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Global Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Market is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the Nasdaq Global Market.

Appears in 1 contract

Samples: Underwriting Agreement (CareDx, Inc.)

Stock Exchange Listing. The shares of Common Stock (including the Common Shares) is are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is are listed on the Nasdaq National MarketThe Nasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Open Market Sale Agreement (Abeona Therapeutics Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed included on the Nasdaq National Market, and the Company has taken no action designed toto terminate, or likely to have the effect ofof terminating, terminating the registration of the Common Stock under the Exchange Act Act, or delisting exclude, or likely to have the effect of excluding, the Common Stock from the Nasdaq National Market, nor has including, without limitation, the five for one reverse stock split of the Company's Common Stock, effective January __, 1998. In addition, the Company has not received any notification that the Commission or the National Association of Securities Dealers, Inc., or the Nasdaq Stock Market, Inc. (collectively, together with NASD Regulation, Inc., the "NASD") is contemplating terminating such registration or listinginclusion.

Appears in 1 contract

Samples: Underwriting Agreement (Ilx Resorts Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and is are listed on the Nasdaq National MarketNasdaq, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Sales Agreement (Sio Gene Therapies Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is Shares are registered pursuant to Section 12(g12(b) of the Exchange 1934 Act and is are listed on the Nasdaq National Global Select Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock Shares under the Exchange 1934 Act or delisting the Common Stock Shares from the Nasdaq National Global Select Market, nor has the Company received any notification that from the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq Global Select Markets is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (First Financial Bancorp /Oh/)

Stock Exchange Listing. The Common shares have been approved for inclusion on the Nasdaq National Market. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. LLC (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Gasonics International Corp)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of under the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, of terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketNasdaq, nor has the Company received any notification information that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") NASD is contemplating contemplated terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Orchid Biosciences Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. Dealers LLC (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Garden Fresh Restaurant Corp /De/)

Stock Exchange Listing. The Company's Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act Act, and is listed the Shares are listed, or have been approved for listing upon notice of issuance, on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock Shares from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. LLC (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Intercept Group Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(b) or 12(g) of the Exchange Act and is listed on the Nasdaq National MarketGlobal Select Market (the “Exchange”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National MarketExchange, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Exchange is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the Exchange.

Appears in 1 contract

Samples: Underwriting Agreement (Humacyte, Inc.)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g) of the Exchange Act and is listed on the Nasdaq National Market, and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities DealersNasdaq Stock Market, Inc. (the "NASD") is contemplating terminating such registration or listing.

Appears in 1 contract

Samples: Underwriting Agreement (Anaren Microwave Inc)

Stock Exchange Listing. The Common Stock (including the Common Shares) is registered pursuant to Section 12(g12(b) of the Exchange Act and Act. The Common Stock is listed on The Nasdaq Global Market (the Nasdaq National Market, and the “Nasdaq”). The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Commission or the National Association of Securities Dealers, Inc. (the "NASD") Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.

Appears in 1 contract

Samples: Subscription Agreement (Cidara Therapeutics, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!